Maraviroc Clinical Trials
4 recruitingDrug
Phase 24Phase 11
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
Hematologic MalignanciesHIV
National Cancer Institute (NCI)265 enrolled1 locationNCT05470491
Recruiting
Phase 2
This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction
Primary Graft Dysfunction
University of California, San Francisco120 enrolled1 locationNCT06853223
Recruiting
Phase 2
Manipulating the Peri-Infarct Area Using Maraviroc to Enhance Motor Skills After Stroke
StrokeIschemic Stroke
Emmanuel Carrera80 enrolled1 locationNCT07080567
Recruiting
Phase 2
The Canadian Maraviroc Randomized Controlled Trial To Augment Rehabilitation Outcomes After Stroke
Stroke
University of Calgary120 enrolled6 locationsNCT04789616